A retrospective study of 12,467 breast cancer patients from 19 Chinese clinical centers reported that the percentage of HER2-low tumors was 56.9%, but the rates varied among laboratories and some centers did not have standardized procedures for detecting HER2 status (17). Here, ERBB2 is linked to breast carcinoma.